ArticleBritish journal of haematology2025

Outcomes of daratumumab-bortezomib-thalidomide-dexamethasone in treatment-naive systemic AL amyloidosis.

Jahanzaib Khwaja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.